Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey O Gillard

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Plos Pathogens|August 11, 2011
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytesGeoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, et al.
Infection and Immunity|October 8, 2014
Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responsesMichael W Panas, Jaimie D Sixsmith, KeriAnn White, et al.
Blood|January 5, 2022
A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in miceAsim Saha, Sharon Hyzy, Tahirih Lamothe, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.
Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos Pathogens|August 11, 2011
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytesGeoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, et al.
Infection and Immunity|October 8, 2014
Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responsesMichael W Panas, Jaimie D Sixsmith, KeriAnn White, et al.
Blood|January 5, 2022
A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in miceAsim Saha, Sharon Hyzy, Tahirih Lamothe, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.
Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Pageof 2